Drug intelligence / Profile preview

Leaton

Development stage
Unknown
Lead developer
Kwizda Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Leaton is a brand of over-the-counter (OTC) dietary supplements developed by the Austrian pharmaceutical company Kwizda Pharma. The product line is formulated to provide a comprehensive blend of essential vitamins and minerals to support daily nutritional needs and address vitamin or mineral deficiencies. The standard formulation includes Vitamin A (Retinol Palmitate), a range of B-complex vitamins (B1, B2, B3, B5, B6, B12), Vitamin C (Ascorbic Acid), Vitamin D2 (Ergocalciferol), and Vitamin E (Alpha Tocopherol). These supplements are intended to promote physical and mental well-being by ensuring the body has the necessary cofactors for metabolic processes and immune function. While the Leaton line includes liquid tonics and syrups, it is also available in oral solid forms such as tablets or capsules.

Brand names
Leaton
Other names
Leaton vitamins/minerals
02

Targets

RBP4 (Retinol-binding protein 4)SNCA (Alpha-synuclein)Aβ (Amyloid-beta peptides and aggregates)

Beyond the preview

Go deeper on Leaton.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leaton.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call